Related Experiment Video

Updated: Jul 17, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

Merits of a new drug trial for ALS?

Ettore Beghi, Caterina Bendotti, Tiziana Mennini

    Science (New York, N.Y.)
    |May 3, 2005
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)
    12:35

    Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)

    Published on: March 17, 2012

    Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
    04:41

    Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

    Published on: February 24, 2026

    Related Experiment Videos

    Last Updated: Jul 17, 2026

    ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
    15:48

    ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

    Published on: July 29, 2007

    Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)
    12:35

    Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)

    Published on: March 17, 2012

    Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
    04:41

    Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

    Published on: February 24, 2026

    Related Concept Videos

    Alzheimer's Disease: Treatment01:22

    Alzheimer's Disease: Treatment

    Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

    Articles linked to this work by shared authors, journal, and citation graph.

    Effects of Lysine Deacetylation Inhibition Alone or in Combination With Arimoclomol on TDP-43 Proteinopathy.

    Journal of neurochemistry·2026

    Microglial Extracellular Vesicles Mediate C1q Deposition at the Pre-Synapse and Promote Synaptic Pruning.

    Journal of extracellular vesicles·2025

    C9ORF72 Is Pivotal to Maintain a Proper Protein Homeostasis in Mouse Skeletal Muscle.

    Cells·2025

    Loss of C9orf72 impacts the peripheral neuromuscular system via immune dysregulation and accelerates the progression of amyotrophic lateral sclerosis in SOD-1 mutant mice.

    Journal of neuroinflammation·2025

    Beneficial effects of synthetic torpor in a fast-progressing mouse model of amyotrophic lateral sclerosis.

    Experimental neurology·2025

    Sephin1 reduces TDP-43 cytoplasmic mislocalization and improves motor neuron survival in ALS models.

    Life science alliance·2025

    In situ structure of the human ciliary transition zone links linker defects to primary ciliary dyskinesia.

    Science (New York, N.Y.)·2026

    Glycan recognition by a plant damage-sensing immune receptor.

    Science (New York, N.Y.)·2026

    Noncoding transcription controls the developmental dynamics of long-range gene regulation.

    Science (New York, N.Y.)·2026

    Catching a glimpse of complex relaxation.

    Science (New York, N.Y.)·2026

    Platinum chemotherapy ages the liver.

    Science (New York, N.Y.)·2026

    Decondensing cancer immunotherapy.

    Science (New York, N.Y.)·2026

    Postoperative infection risk factors in lung cancer patients after bronchoalveolar lavage.

    Journal of thoracic disease·2026

    Real-world safety profile of alectinib: a 10-year pharmacovigilance study based on the FDA adverse event reporting system.

    Frontiers in medicine·2026

    Bronchoalveolar lavage fluid EGFR genotyping during bronchoscopic biopsy: concordance with tissue and additional molecular diagnostic yield in lung cancer.

    Translational lung cancer research·2026

    [Usefulness of Lipiodol Lymphangiography and Computed Tomography in Surgical Management of Chylothorax After Thoracic Aortic Surgery].

    Kyobu geka. The Japanese journal of thoracic surgery·2026

    Evaluation of anti-tumor drugs by simulating physiological absorption and metabolism with a multi-organoid system.

    Cell systems·2026

    Chronic labetalol exposure induced dose-dependent testicular toxicity via disruptingt HPG-axis, spermatogenesis and steroidogenic pathways: A biochemical, molecular and histopathological evidence.

    Tissue & cell·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us